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Abstract
Objectives An increase in the number of CT investigations
will likely result in a an increase in unrequested informa-
tion. Clinical relevance of these findings is unknown. This
is the first follow-up study to investigate the prognostic
relevance of subclinical coronary (CAC) and aortic calci-
fication (TAC) as contained in routine diagnostic chest CT
in a clinical care population.
Methods The follow-up of 10,410 subjects (>40 years)
from a multicentre, clinical care-based cohort of patients
included 240 fatal to 275 non-fatal cardiovascular disease
(CVD) events (mean follow-up 17.8 months). Patients with
a history of CVD were excluded. Coronary (0–12) and
aortic calcification (0–8) were semi-quantitatively scored.
We used Cox proportional-hazard models to compute
hazard ratios to predict CVD events.
Results CAC and TAC were significantly and independently
predictive of CVD events. Compared with subjects with no
calcium, the adjusted risk of a CVD event was 3.7 times
higher (95% CI, 2.7–5.2) among patients with severe
coronary calcification (CAC score ≥6) and 2.7 times higher
(95% CI, 2.0–3.7) among patients with severe aortic
calcification (TAC score ≥5).
Conclusions Subclinical vascular calcification on CT is a
strong predictor of incident CVD events in a routine clinical
care population.
Keywords Coronary artery calcification . Computed
tomography . Cardiovascular disease . Stroke . Prevention
Introduction
Over the last decades, advances in diagnostic imaging
techniques have been impressive. At the same time, this
success has resulted in an increase in unrequested informa-
tion during the diagnostic work-up of patients. Unrequested
information can be defined as imaging abnormalities of
potential clinical relevance that are unexpectedly discov-
ered and unrelated to the clinical indication. Although
unrequested information occurs across different imaging
techniques and anatomical regions, computed tomography
(CT) of the chest provides numerous exemplary cases of
unrequested information: vascular calcifications, pulmonary
emphysema, pulmonary nodules, or skeletal osteoporosis.
Due to lack of follow-up, the clinical importance of
unexpected abnormalities is largely unknown. Performing
follow-up studies is the only way to determine which
imaging abnormalities have or do not have clinical
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relevance. Alternatively, unrequested information could
also contain valuable prognostic information on a variety
of prevalent diseases in an ageing western population
providing a new means of identifying patients that could
profit from primary prevention efforts.
Non-invasive assessment of coronary artery calcium
(CAC) by various CT techniques has been widely used as
a prognostic marker of cardiovascular disease (CVD) in
large prospective screening studies [1–5]. Vascular calcifi-
cations have a high prevalence in the normal population [6]
and will thus be detected frequently when reading diagnos-
tic CT in a clinical care population. To date, no follow-up
studies have been performed to investigate whether vascu-
lar calcifications—as a prevalent example of unrequested
information—can be used as prognostic marker in a
population receiving routine clinical care.
In this study we examined whether subclinical coronary
and/or aortic calcification detected unexpectedly by routine
diagnostic chest CT is associated with future CVD events.
Methods
Population
All subjects are participants of the PROVIDI study, a
multicentre retrospective cohort study among persons
40 years of age and older who underwent chest CT in one
of 8 participating hospitals between January 2002 and
December 2005. In patients with more than one chest CT
examination during follow-up, only the first CT scan was
used for analysis. The original cohort consisted of 23,443
patients. Based on CT reports, a research physician
excluded all patients (n=9077) with a poor prognosis
defined as (1) diagnosis of primary lung cancer (including
mesothelioma), or (2) diagnosis of distant metastatic
disease from other types of cancer (not including haemato-
logical malignancies). This exclusion criterion was applied
as it is highly unlikely that in patients with a poor prognosis
detection of subclinical disease markers will alter clinical
decision making. Similarly, subjects with suspected cardio-
vascular disease or patients known to have symptomatic
cardiovascular disease were excluded (n=2303). Starting
May 2008, CT data of all eligible patients were transferred
to the primary study site to be evaluated for the presence of
unrequested information.
The institutional review boards of all participating
centres approved this study, and written informed consent
was waived because of the retrospective design of this
study; a privacy protocol was implemented.
After exclusion, a total of 12,063 patients were eligible
for this study. All 1653 patients from one randomly chosen
study centre were additionally excluded to be used as an
external validation sample for future research. Chest CT
examinations were thus available for 10,410 patients. A
flow-chart detailing the inclusion and exclusion steps for
this research project is provided as Appendix to this study.
Study design
We used a case-cohort design in which a representative
subcohort (n=1285) is randomly sampled from the baseline
cohort (n=10,410) at the start of the study. This random
sample should be >10% of the size of the baseline cohort
[7]. All participants in the baseline cohort are followed-up
for the outcome-of-interest. Incident cases plus the random
subcohort define the actual population under study. In the
data analysis, all members of the subcohort are weighted by
the inverse sampling fraction to reach valid estimates for
the full cohort. This design provides an efficient way to
avoid scoring CT characteristics for all 10,410 subjects of
the baseline cohort, but instead only in incident cases and a
representative baseline sample.
Chest CT protocols
To mimic day-to-day clinical practice and to increase the
generalisability of our results, we chose to include CT from
a wide spectrum of different CT machines to imaging
protocols. All CT were obtained with dual, 4-, 8-, 16-, 40-,
or 64-slice systems from different vendors. The field-of-
view (FOV) of all eligible chest CT protocols had to
include the heart and the full length of the thoracic aorta.
Slice thickness varied according to the CT indication and
corresponding protocol: e.g. 3 mm for CT pulmonary
embolism, 5 mm for standard chest CT and 10 mm for high-
resolution CT of the lung parenchyma.—CT examinations
with and without intravenous contrast enhancement were
used. One research physician abstracted and classified the CT
indication on the basis of information from CT reports;
examples include suspected pulmonary disease, cardiovascu-
lar disease, traumatic injury, or mediastinal disease.
Scoring of CT characteristics
Computed tomography data sets were scored with regard to
coronary and aortic calcification by three readers: one board
certified radiologist with 10 years of experience and two
research physicians with 2 and 3 years of experience in
reading chest CT. All readers were blinded for patient
characteristics and outcome status. CT images were stored
in DICOM format and read using a commercially available
software program (Dicomworks, version 1.3.5). All CT
were analysed in the axial plane; no other reformatted
planes or thin slice reconstructions were included for
analysis. Readings were performed using a standardised
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score form including information on the type of CT
protocol (section thickness, tube load (mAs) and voltage
(kVp), and the use of contrast agent) and image quality
(defined as good, adequate or poor).
The extent of vascular calcification was scored using
simple visual grading (0–3) as previously described [8].
Table 1 provides exact definitions. Briefly, the four main
coronary artery branches were scored separately (0–3) before
being summed into a single score for the coronary artery tree
(0–12). Calcification of the thoracic aorta was scored in three
locations: calcification in the ascending (0–3) and descend-
ing (0–3) aorta and calcification in the supra-aortic arteries
branching of the aortic arch (0–2), which were summed into
a single score for the thoracic aorta (0–8). The lower cut-off
level for the descending aorta was defined as the mid-level of
the 11th thoracic vertebra. Figure 1 provides a visual
example of different grades of CAC.
Use of the score form was trained under the supervision of
an experienced board certified chest radiologist using a
training set of 50 randomly selected patients. Reproducibility
of visual grading was evaluated. Briefly, weighted kappa
for inter -and intra-observer variability of aortic wall
abnormalities (including calcifications) were 0.72 and
0.88, for calcifications of the supra-aortic arteries 0.89
and 0.96, and for calcifications in the coronary arteries
0.77 and 0.91, respectively.
Follow-up
We recorded incident fatal and non-fatal CVD events for a
mean of 17.8 months. End-point status was obtained
through linkage of patients with the National Death
Registry and the National Registry of Hospital Discharge
Diagnoses from January 2002 to December 2005. Database
linkage was performed with a validated probabilistic
method [9–12]. In these databases, cause of death and the
occasion of hospitalisation are coded according to the
International Classification of Diseases, 9th and 10th
revision (ICD-9, ICD-10) [13]. Correct designation of
causes of death has been established with in a comparison
study with patient medical records [14]. The incidence of
CVD events in the full cohort of 10,410 participants was
n=515.
A trained research physician abstracted all valid end
points from these databases on the basis of ICD codes.
Fatal and non-fatal CVD events were defined by ICD-9
codes as coronary heart disease (CHD) (codes 410–414),
heart failure (code 428), peripheral arterial disease (PAOD)
(codes 440, 443–444), aortic aneurysm (code 441), cere-
brovascular disease (codes 430–438), or non-rheumatic
valvular disease (code 424). All other codes included in the
ICD-9 paragraph on diseases of the circulatory system were
not considered as valid end points for this study. In the case
of multiple valid end points in the same patient, cause of
death prevailed over hospital admissions or else the first
hospital discharge diagnosis was used. Secondary analyses
were performed for a selection of cases from the primary
end point: all fatal and non-fatal coronary events (codes
410–414) and all fatal and non-fatal non-cardiac events
(PAOD, codes 440, 443–444; aortic aneurysm, code 441;
and cerebrovascular events, codes 430–438).
Data analysis
Differences in risk factors and CT protocols between
subjects from the subcohort to various case-groups were
tested with Chi-squared tests (discrete variables) and one-
way ANOVA (continuous variables). Next, we calculated
annualised event rates for all three end points stratified
according to coronary and aortic calcium scores.
We used Cox proportional-hazards regression to estimate
hazard ratios for any CVD event, coronary events, and any
non-cardiac event according to calcium scores. Sum scores for
visually graded coronary and aortic calcifications were
analysed as categorical and as continuous variables (per
SD). Categories of the aortic calcification sum score (0–8)
Table 1 Definitions used for visual grading of calcified plaques on routine diagnostic chest CT
Finding (potential range) Grades
0 1 2 3
Aortic wall calcification (0–3)
(score for ascending and
descending aorta separately)
absent ≤3 foci 4–5 foci or 1 calcification
extending over ≥3 slicesa
>5 foci or 1 calcification
extending over ≥3 slice
Supra-aortic artery calcification (0–2) absent calcifications in 1
supra-aortic artery
calcifications in >1 supra-aortic
arteries
Coronary calcification (0–3) (score per
main branch: LM,LAD,LCX, RCA)
absent 1–2 foci >2 foci or 1 calcification
extending over ≥2 slices
calcified arteries covering a
large segment of a coronary
branch
a Values are based on standard chest CT protocols with 5 mm section thickness
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were chosen as: no calcification (reference category), mild
calcification (sum score 1–2), moderate calcification (sum
score 3–4) and severe calcification (sum score 5 and higher).
In the case of coronary calcifications (0–12), category cut-offs
were chosen as: no calcification (reference category), mild
calcification (sum score 1–2), moderate calcification (sum
score 3–5) and severe calcification (sum score 5 and higher).
After estimating the hazard ratios for all non-cardiac
events according to the aortic sum score, we performed
additional regression analyses for all cases of stroke,
looking at calcifications in each anatomically distinct part
of the thoracic aorta (ascending, descending, arch). Finally,
we investigated the multivariate associations when coro-
nary and aortic sum scores were modelled simultaneously.
Apart from crude associations, all models were adjusted
for age, sex, indication for CT, image quality to type of
medical centre in which the CT was performed (tertiary/
secondary). We also tested the interaction of aortic and
coronary sum scores with section thickness (continuous)
and the use of contrast agent (yes/no) by entering
interaction terms into the model. We had missing values
for CT characteristics in <3%. We used regression methods
implemented in SPSS software (SPSS 14.0, Chicago, IL,
USA) to impute missing values. All other analyses were
performed with R software, version 6.2.
Results
A total of 116 subjects (39 of 515 cases (7.6%), and 77 of 1285
subjects from the subcohort (6.0%)) were excluded from
analyses because CT images could not be retrieved from CT
databases. A total of 515 subjects had a CVD event during
follow-up: fatal CVD events occurred in 240 patients, and 275
patients had a non-fatal event. Table 2 summarises the baseline
characteristics of the subcohort and the various case-groups.
Table 3 shows a gradual increase in annualised event rate
for any CVD event with increasing CAC and TAC score
categories.
Subjects with coronary and non-cardiac events were
older than people in the subcohort, but only subjects with
coronary events were more often male.
The prevalence of CAC (sum score >0) was 67% for people
in the subcohort compared with 88% in subjects with CVD
events, 90% for coronary events, and 85% for non-cardiac
events (P<0.001 for all three groups). The corresponding
figures for TAC >0 were 61% (subcohort), 82%, 80% and
86%, respectively (P<0.001 for all three groups).
Table 4 shows that the risk of any CVD event increases
with an increase in category of TAC and CAC scores after
Fig. 1 Axial 16-slice CT images of different grades of coronary artery
calcification in the left anterior descending (LAD) branch (arrows
demonstrate the example area): a grade 1 (2 focal calcifications); b
grade 2 (1 large calcification); c grade 3 (extensive calcification
covering a large segment of the LAD branch)
b
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adjustment for age, sex, CT indication, CT image quality and
type of medical centre. A statistically significant increase in
hazard ratio occurs already in the case of mild calcification
(TAC and CAC scores = 1–2). The risk of any CVD event
was increased by a factor of 2.7 (95% CI, 2.0–3.7) and 3.7
(95% CI, 2.7–5.2), respectively, among patients with severe
TAC or CAC (TAC score ≥5; CAC score ≥6) compared with
those without any calcium. In order to compare the strength
of the associations between the two calcium measures, Table 4
also shows the increase in risk of any CVD event associated
with CAC and TAC as continuous measures (per 1 SD
increase in the TAC and CAC sum scores). After adjustment,
an increase of 1 SD in TAC and CAC sum scores resulted in
a 46% and 41% increase in the risk of any CVD event.
Looking at coronary and non-cardiac events separately
(Table 4, lower half), we could demonstrate a more differen-
tiated pattern in the associations with TAC and CAC scores.
Risk of coronary events increased 5-fold among subjects with
severe CAC (CAC score ≥6) compared with those without any
coronary calcium, whereas having severe TAC (TAC score ≥5)
resulted in an increase in risk by a factor of 2.4. Conversely, risk
of non-cardiac events (stroke, aortic aneurysm/dissection,
PAOD) increased by a factor of 3.3 for subjects with severe
TAC compared with patients without any aortic calcium,
Table 3 Annualised event rates for any CVD event (n=515)
according to coronary artery calcium score and thoracic aorta calcium
score categories
Annualised event rates
TAC risk category CAC risk category
None (0) 1.0 (95) None (0) 0.7 (62)
Mild (1–2) 1.9 (127) Mild (1–2) 2.2 (111)
Moderate (3–4) 5.0 (170) Moderate (3–5) 3.1 (150)
Severe (≥5) 5.6 (123) Severe (≥6) 5.9 (192)
Data are percentages. Data in parentheses are numbers of patients.









Age (years) 61.5±11.9 67.9±11.3 68.1±11.0 67.8±11.3
Male sex (%) 58 65 68 58
CT indication (%)
Pulmonary disease 37 47 50 37
Haematological malignancy 11 6 6 5
Mediastinal disease 11 8 10 8
Ruled-out pulmonary malignancy 24 21 18 27
Pulmonary embolism 6 8 6 12
Other 11 10 10 11
Image quality (%)
Good 72 74 76 69
Adequate 24 24 23 27
Poor 3 2 1 4
Tertiary medical centre (%) 77 77 78 73
Use of contrast agent (%) 68 67 66 70
Section thickness (mm)
1–3 mm 43 41 43 36
4–6 mm 39 38 38 37
>6 mm 18 21 19 27
Thoracic aortic calcium (sum score)
None (0) 39 18 20 14
Mild (1–2) 30 25 23 29
Moderate (3–4) 19 33 33 35
Severe (≥5) 12 24 24 22
Coronary artery calcium (sum score)
None (0) 33 12 10 15
Mild (1–2) 24 22 20 25
Moderate (3–5) 25 29 28 27
Severe (≥6) 18 37 42 32
Table 2 Baseline characteristics
Values are means±SD or
proportions
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whereas people with severe CAC showed an increase in risk by
a factor of 2.3. No statistically significant interaction was found
between section thickness and TAC (P=0.46) or CAC (P=
0.89) and the use of intravenous contrast and TAC (P=0.40)
or CAC (P=0.81) in relation to the risk of CVD events.
Table 5 shows the risk of stroke associated with
increasing amounts of calcium in each of the three
anatomically distinct parts of the thoracic aorta. Remarkably,
strongest associations (and the only to reach statistical
significance) were demonstrated for calcifications in the
ascending aorta. Moderate calcification of the ascending
aorta increased the risk of stroke by a factor 3.0 compared
with no calcification, whereas moderate calcification of the
descending aorta or supra-aortic branches increased the risk
by a factor of 1.8 and 1.4, respectively.
We also calculated multivariate-adjusted models with TAC
and CAC sum scores entered simultaneously. Both scores
were independently associated with the risk of (1) any CVD
event increasing the risk by 25% (95% CI, 13–38%) per 1 SD
increase in CAC score and 30% (95% CI, 17–44%) per 1 SD
increase in TAC score, respectively; and (2) coronary events
increasing the risk by 42% (95% CI, 25–61%) per 1 SD
increase in CAC score and 19% (95% CI, 4–36%) per 1 SD
increase in TAC score, respectively. Only TAC was indepen-
dently associated with the risk of non-cardiac events (45%
increased risk per 1 SD increase in TAC score).
Discussion
More than 60 million diagnostic CT are performed
annually in the USA and this number will likely increase as
the population continues to age [15]. These diagnostic images
Table 4 Risk of any CVD event, coronary events, and non-cardiac events associated with increasing coronary artery calcium score and thoracic
aorta calcium score in clinical care patients undergoing routine diagnostic chest CT
End points Hazard ratios (95% CI)
Crude Full modela Crude Full modela
Any CVD event (n=515)
TAC categories CAC categories
None (0) 1.0 1.0 None (0) 1.0 1.0
Mild (1–2) 1.8 (1.4–2.4) 1.4 (1.0–1.8) Mild (1–2) 2.8 (2.0–3.8) 2.2 (1.6–3.0)
Moderate (3–4) 4.4 (3.4–5.6) 2.6 (1.9–3.4) Moderate (3–5) 3.8 (2.9–5.2) 2.5 (1.8–3.4)
Severe (≥5) 4.9 (3.8–6.4) 2.7 (2.0–3.7) Severe (≥6) 6.9 (5.2–9.2) 3.7 (2.7–5.2)
Continuousb 1.76 (1.64–1.90) 1.46 (1.33–1.60) Continuousb 1.73 (1.61–1.85) 1.41 (1.30–1.54)
Coronary events (n=310)
TAC categories CAC categories
None (0) 1.0 1.0 None (0) 1.0 1.0
Mild (1–2) 1.5 (1.1–2.2) 1.2 (0.8–1.7) Mild (1–2) 3.0 (1.9–4.6) 2.4 (1.5–3.7)
Moderate (3–4) 4.0 (3.0–5.5) 2.3 (1.6–3.3) Moderate (3–5) 4.3 (2.9–6.4) 2.9 (1.9–4.4)
Severe (≥5) 4.6 (3.3–6.4) 2.4 (1.6–3.5) Severe (≥6) 9.1 (6.2–13.4) 5.0 (3.2–7.7)
Continuousb 1.76 (1.60–1.94) 1.43 (1.27–1.60) Continuousb 1.87 (1.71–2.05) 1.54 (1.38–1.72)
Non-cardiac events (n=128)c
TAC categories CAC categories
None (0) 1.0 1.0 None (0) 1.0 1.0
Mild (1–2) 2.6 (1.5–4.5) 1.9 (1.1–3.4) Mild (1–2) 2.5 (1.4–4.3) 1.8 (1.0–3.3)
Moderate (3–4) 5.6 (3.3–9.7) 3.5 (1.9–6.4) Moderate (3–5) 2.7 (1.6–4.7) 1.7 (0.9–3.0)
Severe (≥5) 5.5 (3.1–9.8) 3.3 (1.7–6.4) Severe (≥6) 4.5 (2.6–7.6) 2.3 (1.3–4.3)
Continuousb 1.71 (1.47–1.98) 1.45 (1.21–1.73) Continuousb 1.48 (1.28–1.72) 1.20 (1.00–1.43)
a Full Model: adjusted for age, sex, clinical indication for chest CT, image quality, and type of medical centre
b Hazard ratios for continuous TAC/CAC scores are calculated per 1 standard deviation increase in CAC (SD = 3.022) or TAC (SD = 1.952)
c Non-cardiac events were fatal and non-fatal cases of stroke, aortic aneurysm/dissection and peripheral arterial occlusive disease
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We examined whether unrequested information from
routine diagnostic chest CT in a clinical care population
could be used as predictor of future disease. Severe
coronary (CAC) or aortic (TAC) calcification—based on
visual grading of calcified plaques—increased the risk of any
CVD event almost 4-fold and 3-fold, respectively, after a
mean follow-up of close to one and a half years. CAC was
found to be a stronger predictor of coronary events, whereas
TAC was more strongly associated with non-cardiac events.
contain unrequested, subclinical findings that could contain
important prognostic information. Obtaining this information
is ‘free’, as it is contained in routine care and comes at no
additional exposure to ionising radiation. Currently, no data are
available on the natural course and prognosis of these findings.
The prognostic value (or lack thereof) of unrequested
subclinical findings is important to indicate new ways of
extracting clinically relevant information. Results from this
study suggest that CT images obtained as part of routine
clinical care do indeed convey important ancillary information.
We investigated the prognostic value of coronary and aortic
calcifications as these are highly prevalent [6] and long
recognised as prognostic markers of CVD in asymptomatic
screening populations [1–5]. The prevalence of any CAC in
our study (67%) is comparable with these previous studies
specifically aimed at screening for CAC and showing ranges
between 53 and 69% [2, 16, 17]. Like these screening studies
we show that CAC is a strong predictor of future CVD events.
However, to our knowledge, our results are the first to
demonstrate this association in a routine clinical care
population. Furthermore, we used a simple visual grading to
score calcifications on a heterogeneous set of CT protocols.
Existing calcium scoring typically involves non-contrast-
enhanced, ECG-gated CT protocols with semi-automatic
calcium scoring software. The scoring method we used
consists of simple definitions, is reproducible, can be
performed with a minimum of additional reviewing time and
can be applied to a whole range of different CT protocols
(including non-gated CT). Prognostic information on CVD
risk can be appended to the CT report. Together with all
relevant clinical data available from a patient’s medical
record, the clinician can decide whether additional work-up
is required. This will result in a more consistent and clinically
useful way of reporting unrequested subclinical findings.
Cardiovascular disease is one of the leading causes of
death and hospitalisations in western society [18]. Major
advances in knowledge about CVD risk factors have been
made in recent decades and international guidelines for the
primary prevention of CVD have been actively developed
[19–21]. However, for a variety of reasons substantial groups
of people at intermediate or high risk of CVD events
according to existing guidelines are currently not recognised
and treated as such [22, 23]. This has prompted expert panels
to state that the search for new strategies to detect patients
who would benefit most from intensive primary prevention
efforts is a clinically important objective [24, 25]. The
present study is an attempt at defining such a new strategy.
Unfortunately, no information from patients’ medical
records was available for this study. This might have
influenced our results in two ways. First, exclusion of
patients with symptomatic CVD could now only be
performed based on information from CT reports, possibly
resulting in a number of symptomatic CVD patients being
missed. This would have caused an overestimation of our
risk ratios. However, we excluded approximately 16% of
patients from the baseline clinical care cohort based on
information from CT reports (2,303/14,366) which is
slightly more than the prevalence of symptomatic CVD
(11.2%) in the general white population of the USA [26].
Second, lack of information from medical records pre-
vented us from adjusting our risk estimates for traditional
CVD risk factors (hypertension, hyperlipidaemia, diabetes,
smoking). Based on previous reports we expect that only
limited attenuation of our age- and sex-adjusted risk
estimates will occur when adjusting additionally for other
CVD risk factors [3].
Conclusion
Unrequested subclinical findings—such as coronary and
aortic calcifications—detected on routine care, diagnostic
chest CT in a clinical care population can be used as a
prognostic marker of future CVD events. This may be
achieved with a simple visual scoring method that is easy to
use in daily clinical practice. This offers a novel approach
in trying to employ potentially valuable prognostic infor-
mation contained in routine diagnostic imaging and may be
used to identify patients who could benefit from primary
preventive efforts.
Table 5 Risk of stroke (n=58) associated with calcium in three
anatomically distinct parts of the thoracic aorta
Site Hazard ratios (95% CI)
Crude Full modela
Ascending aorta (0–3)
None (0) 1.0 1.0
Mild (1) 3.2 (1.9–5.6) 2.2 (1.3–4.0)
Moderate (2) 4.7 (2.0–11.3) 3.0 (1.1–7.6)
Severe (3) Infb Infb
Descending aorta (0–3)
None (0) 1.0 1.0
Mild (1) 3.0 (1.6–5.8) 1.8 (0.9–3.7)
Moderate (2) 3.9 (1.8–8.2) 1.8 (0.8–4.2)
Severe (3) 5.9 (2.5–13.8) 3.0 (1.1–7.8)
Supra-aortic branches (0–2)
None (0) 1.0 1.0
Moderate (1) 2.4 (1.2–4.5) 1.4 (0.7–2.7)
Severe (2) 3.1 (1.7–5.9) 1.7 (0.8–3.4)
a Full Model: adjusted for age, sex, clinical indication for chest CT,
image quality and type of medical centre
b Due to the limited number of stroke events, no cases occurred in the
highest TAC category for the ascending aorta and consequently no
hazard ratio could be calculated
Eur Radiol (2011) 21:1577–1585 1583
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